Published in JAMA Surg on June 01, 2015
Determining Chances for Survival in Intrahepatic Cholangiocarcinoma. JAMA Surg (2015) 0.76
Conditional probability of long-term survival after resection of hilar cholangiocarcinoma. HPB (Oxford) (2016) 0.75
Conditional disease-free survival after liver transplantation for hepatocellular carcinoma: A two-center experience. Medicine (Baltimore) (2016) 0.75
Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther (2017) 0.75
Patient perceptions regarding the likelihood of cure after surgical resection of lung and colorectal cancer. Cancer (2015) 1.82
Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis. JAMA Surg (2015) 1.46
Potential Economic Impact of Using a Restrictive Transfusion Trigger Among Patients Undergoing Major Abdominal Surgery. JAMA Surg (2015) 1.42
Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma. JAMA Surg (2016) 1.42
Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis. Ann Surg Oncol (2014) 1.00
Anatomic versus nonanatomic resection in cirrhotic patients with early hepatocellular carcinoma. Surgery (2013) 0.97
Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years. Cancer (2014) 0.94
Tracking early readmission after pancreatectomy to index and nonindex institutions: a more accurate assessment of readmission. JAMA Surg (2015) 0.86
Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection. Ann Surg Oncol (2015) 0.84
See one, do one, and teach none: resident experience as a teaching assistant. J Surg Res (2015) 0.81
Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma. J Surg Oncol (2015) 0.80
Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy. J Am Coll Surg (2015) 0.79
The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol (2015) 0.78
Long-term therapy with sorafenib is associated with pancreatic atrophy. J Surg Res (2015) 0.77
A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma. J Surg Oncol (2016) 0.76
Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis. Surgery (2016) 0.76
The effect of preoperative chemotherapy treatment in surgically treated intrahepatic cholangiocarcinoma patients-A multi-institutional analysis. J Surg Oncol (2017) 0.75
Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patients. J Surg Oncol (2017) 0.75
Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma. J Surg Oncol (2017) 0.75
Prognostic impact of complications after resection of early stage hepatocellular carcinoma. J Surg Oncol (2017) 0.75
Risk factors and prediction model for inpatient surgical site infection after major abdominal surgery. J Surg Res (2017) 0.75